부산대학교 도서관

Johansson, CB; Youssef, S; Koleckar, K; Holbrook, C; Doyonnas, R; Corbel, SY; Steinman, L; Rossi, FMV; Blau, HM

Nature cell biology. 10(5):575-583

Wehrman, T. S.; Raab, W. J.; Casipit, C. L.; Doyonnas, R.; Pomerantz, J. H.; Blau, H. M.

Proceedings of the National Academy of Sciences of the United States of America, 2006 Dec 01. 103(50), 19063-19068.

Bourdenet, S.; Doyonnas, R.; Vacheron, M.-J.; Guinand, M.; Fasciotto, B.; Ristic, A.; Michel, G.; Cozzone, A.J.; Durkin, J.P.; Whitfield, J.F.; Krsmanovic, V.

Cancer Letters. 50(2):121-127

Jorgensen-Tye, B.; Levesque, J.-P.; Royle, L.; Doyonnas, R.; Chan, J. Y.-H.; Dwek, R. A.; Rudd, P. M.; Harvey, D. J.; Simmons, P. J.; Watt, S. M.

Tissue Antigens. Mar 01, 2005 65(3):220-239

Streetz, K.L.; Doyonnas, R.; Jenkins, D.; Perryman, S.; Fuess, S.; Lin, S.; Shizuru, J.; Blau, H.; Trautwein, C.; Sylvester, K.; Kay, M.A.

Journal of Hepatology. 44:S33-S33

Vincent F; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA. Electronic address: fabien.vincent@pfizer.com.; Loria PM; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.; Weston AD; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.; Steppan CM; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.; Doyonnas R; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.; Wang YM; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.; Rockwell KL; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.; Peakman MC; Discovery Sciences, Pfizer, 445 Eastern Point Road, Groton, CT 06340, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE

Berg A; 1 Rare Disease Research, Pfizer Inc., Cambridge, MA, USA.; Hallowell S; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Tibbetts M; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Beasley C; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Brown-Phillips T; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Healy A; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Pustilnik L; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Doyonnas R; 2 Primary Pharmacology Group, Medicine Design, Pfizer Inc., Groton, CT, USA.; Pregel M; 1 Rare Disease Research, Pfizer Inc., Cambridge, MA, USA.

Publisher: SAGE Publications Country of Publication: United States NLM ID: 101697563 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2472-5560 (Electronic) Linking ISSN: 24725552 NLM ISO Abbreviation: SLAS Discov Subsets: MEDLINE

Sawant-Basak A; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.). aarti.sawant@pfizer.com.; Rodrigues AD; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.).; Lech M; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.).; Doyonnas R; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.).; Kasaian M; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.).; Prasad B; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.).; Tsamandouras N; Pfizer Worldwide Research & Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (A.S.-B.); Pfizer Worldwide Research & Development, PDM, Eastern Point Road, Groton, 06340 (A.D.R.); Pfizer Worldwide Research & Development, Inflammation and Immunology, 1 Portland Street, Cambridge, MA 02139 (M.L., M.K.); Pfizer Worldwide Research & Development, Discovery Sciences, Eastern Point Road, Groton, 06340 (R.D.); Assistant Professor, Department of Pharmaceutics, UWRAPT H268, Health Science Building, Seattle (B.P.); Pfizer Worldwide Research & Development, Early Clinical Development, Clinical Pharmacology, 1 Portland Street, Cambridge, MA 02139 (N.T.).

Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Vincent F; Hit Discovery and Lead Profiling, Pfizer, Groton, CT 06340, USA. fabien.vincent@pfizer.com.; Loria P; Hit Discovery and Lead Profiling, Pfizer, Groton, CT 06340, USA.; Pregel M; Rare Diseases Research Unit, Pfizer, Cambridge, MA 02139, USA.; Stanton R; Worldwide Medicinal Chemistry, Pfizer, Groton, CT 06340, USA.; Kitching L; Neusentis Research Unit, Pfizer, Cambridge CB21 6GS, UK.; Nocka K; Immunology and Inflammation Research Unit, Pfizer, Cambridge, MA 02139, USA.; Doyonnas R; Hit Discovery and Lead Profiling, Pfizer, Groton, CT 06340, USA.; Steppan C; Hit Discovery and Lead Profiling, Pfizer, Groton, CT 06340, USA.; Gilbert A; Worldwide Medicinal Chemistry, Pfizer, Groton, CT 06340, USA.; Schroeter T; Hit Discovery and Lead Profiling, Pfizer, Groton, CT 06340, USA.; Peakman MC; Hit Discovery and Lead Profiling, Pfizer, Groton, CT 06340, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Wehrman, T. S.; Raab, W. J.; Casipit, C. L.; Doyonnas, R.; Pomerantz, J. H.; Blau, H. M.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; DEC 12 2006, 103 50, p19063-p19068, 6p.